美国公共卫生中膀胱过度活动症的负担
The Burden of Overactive Bladder on US Public Health.
作者信息
Reynolds W Stuart, Fowke Jay, Dmochowski Roger
机构信息
Department of Urologic Surgery, Female Pelvic Medicine and Reconstructive Surgery, Vanderbilt University Medical Center, A1302 Medical Center North, Nashville, TN 37232, USA.
Department of Urologic Surgery, Vanderbilt Epidemiology Center, Institute of Medicine and Public Health, Vanderbilt University Medical Center, 12th floor, Nashville, TN 37232, USA.
出版信息
Curr Bladder Dysfunct Rep. 2016 Mar;11(1):8-13. doi: 10.1007/s11884-016-0344-9. Epub 2016 Jan 23.
Abstract
Overactive bladder (OAB) is a highly prevalent symptom condition that affects millions of US men and women. Not only can the symptoms of OAB be very bothersome, but OAB can have significant detrimental effects on many aspects of individuals' lives, representing a particularly impactful health burden to quality of life and productivity. Estimates of the individual and societal costs for the management of OAB continue to rise, particularly as effective treatments remain elusive. As such, OAB represents a significant public health burden to the USA.
摘要
膀胱过度活动症（OAB）是一种非常普遍的症状性疾病，影响着数百万美国男性和女性。OAB的症状不仅会非常令人困扰，而且会对个人生活的许多方面产生重大不利影响，对生活质量和生产力构成特别严重的健康负担。用于管理OAB的个人和社会成本估计持续上升，尤其是因为仍然难以找到有效的治疗方法。因此，OAB给美国带来了重大的公共卫生负担。
相似文献
1
The Burden of Overactive Bladder on US Public Health.
Curr Bladder Dysfunct Rep. 2016 Mar;11(1):8-13. doi: 10.1007/s11884-016-0344-9. Epub 2016 Jan 23.
2
Insights into the Management of Overactive Bladder with Transdermal Oxybutynin: A Practical Review.
Res Rep Urol. 2020 Aug 14;12:321-330. doi: 10.2147/RRU.S266400. eCollection 2020.
3
The impact of overactive bladder on mental health, work productivity and health-related quality of life in the UK and Sweden: results from EpiLUTS.
BJU Int. 2011 Nov;108(9):1459-71. doi: 10.1111/j.1464-410X.2010.10013.x. Epub 2011 Mar 3.
4
What is the real burden of the overactive bladder? Results from a national prevalence study.
Neurourol Urodyn. 2022 Apr;41(4):926-934. doi: 10.1002/nau.24894. Epub 2022 Mar 1.
5
Pharmacotherapy of overactive bladder: epidemiology and pathophysiology of overactive bladder.
Expert Opin Pharmacother. 2011 May;12(7):1017-27. doi: 10.1517/14656566.2011.554396. Epub 2011 Feb 26.
6
The prevalence of overactive bladder and its impact on the quality of life: A cross-sectional study.
Arab J Urol. 2023 Jun 10;22(1):39-47. doi: 10.1080/2090598X.2023.2221403. eCollection 2024.
7
Defining overactive bladder: epidemiology and burden of disease.
Urology. 2004 Dec;64(6 Suppl 1):2-6. doi: 10.1016/j.urology.2004.10.047.
8
Management of Patients with Overactive Bladder in Brazil: A Retrospective Observational Study Using Data From the Brazilian Public Health System.
Adv Ther. 2020 May;37(5):2344-2355. doi: 10.1007/s12325-020-01318-w. Epub 2020 Apr 15.
9
Prevalence of overactive bladder in China, Taiwan and South Korea: Results from a cross-sectional, population-based study.
Low Urin Tract Symptoms. 2019 Jan;11(1):48-55. doi: 10.1111/luts.12193. Epub 2017 Oct 2.
10
Prevalence, risk factors, and impact on health related quality of life of overactive bladder in China.
Neurourol Urodyn. 2011 Nov;30(8):1448-55. doi: 10.1002/nau.21072. Epub 2011 Aug 8.
引用本文的文献
1
Association between magnesium depletion score and overactive bladder among U.S. Adults using data from NHANES 2005-2018.
Sci Rep. 2025 Sep 1;15(1):32193. doi: 10.1038/s41598-025-17962-7.
2
Smooth muscle of the lower urinary tract: BK-RyR coupling in physiology and pathophysiology.
J Muscle Res Cell Motil. 2025 Sep 1. doi: 10.1007/s10974-025-09707-w.
3
Overactive bladder symptoms profile and related factors among women during the perinatal period: a latent profile analysis.
BMC Pregnancy Childbirth. 2025 Aug 14;25(1):850. doi: 10.1186/s12884-025-07996-0.
4
Ethnic and racial social identity, socioeconomic position, and women's bladder health.
Soc Sci Med. 2025 Jan 16:117694. doi: 10.1016/j.socscimed.2025.117694.
5
Mediating role of SII in the association between LC9 and overactive bladder.
Sci Rep. 2025 Jul 30;15(1):27808. doi: 10.1038/s41598-025-13669-x.
6
Abnormal Cerebral Perfusion and Functional Connectivity in Women with Overactive Bladder.
Brain Sci. 2025 Jun 27;15(7):689. doi: 10.3390/brainsci15070689.
7
Concomitant Overactive Bladder Treatment and Adherence to Pelvic Floor Physical Therapy.
Int Urogynecol J. 2025 Jul 22. doi: 10.1007/s00192-025-06209-8.
8
Association between overactive bladder and suicidal ideation in US adults: a population-based study.
Front Psychiatry. 2025 Jun 9;16:1483684. doi: 10.3389/fpsyt.2025.1483684. eCollection 2025.
9
Intravesical Onabotulinum Toxin A Injection Paradigms for Idiopathic Overactive Bladder: A Scoping Review of Clinical Outcomes, Techniques, and Implications for Practice and Future Research.
Toxins (Basel). 2025 Apr 23;17(5):211. doi: 10.3390/toxins17050211.
10
Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN II) Urinary Urgency Phenotyping Study: Methods and Baseline Urinary Symptoms by Age and Sex.
Neurourol Urodyn. 2025 Jun;44(5):1007-1021. doi: 10.1002/nau.70044. Epub 2025 Apr 24.
本文引用的文献
1
Comparative Effectiveness of Anticholinergic Therapy for Overactive Bladder in Women: A Systematic Review and Meta-analysis.
Obstet Gynecol. 2015 Jun;125(6):1423-1432. doi: 10.1097/AOG.0000000000000851.
2
Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment.
J Urol. 2015 May;193(5):1572-80. doi: 10.1016/j.juro.2015.01.087. Epub 2015 Jan 23.
3
Affective symptoms and the overactive bladder - a systematic review.
J Psychosom Res. 2015 Feb;78(2):95-108. doi: 10.1016/j.jpsychores.2014.11.019. Epub 2014 Nov 27.
4
The psychological impact of overactive bladder: A systematic review.
J Health Psychol. 2016 Jan;21(1):69-81. doi: 10.1177/1359105314522084. Epub 2014 Mar 2.
5
Impact of urinary incontinence on healthcare resource utilization, health-related quality of life and productivity in patients with overactive bladder.
BJU Int. 2014 Mar;113(3):484-91. doi: 10.1111/bju.12505.
6
Treatment status and risk factors for incidence and persistence of urinary incontinence in women.
Int Urogynecol J. 2014 Jun;25(6):775-82. doi: 10.1007/s00192-013-2288-3. Epub 2014 Jan 30.
7
Anticholinergic medication use for female overactive bladder in the ambulatory setting in the United States.
Int Urogynecol J. 2014 Apr;25(4):479-84. doi: 10.1007/s00192-013-2246-0. Epub 2013 Oct 25.
8
Long-term patterns of use and treatment failure with anticholinergic agents for overactive bladder.
Clin Ther. 2013 Nov;35(11):1744-51. doi: 10.1016/j.clinthera.2013.08.017. Epub 2013 Oct 3.
9
Comorbidities and personal burden of urgency urinary incontinence: a systematic review.
Int J Clin Pract. 2013 Oct;67(10):1015-33. doi: 10.1111/ijcp.12164.
10
The impact of OAB on physical activity in the United States: results from OAB-POLL.
Urology. 2013 Oct;82(4):799-806. doi: 10.1016/j.urology.2013.05.035. Epub 2013 Aug 14.
Zotero 插件